Ticker > Company >

Valiant Organics share price

Valiant Organics Ltd.

NSE: VALIANTORG BSE: 540145 SECTOR: Chemicals  95.09 K   320   29

263.35
+4.65 (1.80%)
BSE: 09 Jan 04:01 PM

Price Summary

Today's High

₹ 263.35

Today's Low

₹ 251.95

52 Week High

₹ 508.3

52 Week Low

₹ 225

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

737.9 Cr.

Enterprise Value

941.82 Cr.

No. of Shares

2.8 Cr.

P/E

33.89

P/B

1.09

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  240.97

CASH

7.43 Cr.

DEBT

211.36 Cr.

Promoter Holding

37.91 %

EPS (TTM)

₹  7.77

Sales Growth

6.14%

ROE

-0.45 %

ROCE

2.97%

Profit Growth

1.48 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year6.14%
3 Year-8.83%
5 Year4.26%

Profit Growth

1 Year1.48%
3 Year-130.77%
5 Year-147.51%

ROE%

1 Year-0.45%
3 Year3.67%
5 Year11.09%

ROCE %

1 Year2.97%
3 Year5.62%
5 Year12.43%

Debt/Equity

0.3196

Price to Cash Flow

12.6

Interest Cover Ratio

1.1019

CFO/PAT (5 Yr. Avg.)

1.49651981533302

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2025 37.91 0.00
Jun 2025 37.91 0.00
Mar 2025 37.91 0.00
Dec 2024 37.74 0.00
Sep 2024 37.77 0.21
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of 7.86709999999999 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.49651981533302.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 7.61530905711777.

 Limitations

  • The company has shown a poor profit growth of -130.768358924447% for the Past 3 years.
  • The company has shown a poor revenue growth of -8.8288018030014% for the Past 3 years.
  • Company has a poor ROE of 3.6712% over the past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Net Sales 160.18 186.86 203.81 204.41 157.21
Total Expenditure 157.81 171.53 183.52 179.58 136.05
Operating Profit 2.36 15.33 20.29 24.83 21.16
Other Income 2.02 5.04 0.67 1.07 0.2
Interest 8.25 5.83 4.65 6 4.21
Depreciation 8.79 8.99 9.2 9.42 9.78
Exceptional Items 0 0 0 0 0
Profit Before Tax -12.65 5.55 7.11 10.48 7.36
Tax -1.5 0.91 3.15 2.91 1.76
Profit After Tax -11.16 4.65 3.96 7.58 5.6
Adjusted EPS (Rs) -4.04 1.68 1.41 2.71 2

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 574.24 948.45 911.62 677.19 718.76
Total Expenditure 416.98 783.41 781.63 638.07 665.21
Operating Profit 157.26 165.04 129.99 39.12 53.56
Other Income 16.9 5.56 2.92 3.34 8.25
Interest 3.49 6.35 10.54 19.38 23.64
Depreciation 18.63 27.29 27.63 33.97 35.76
Exceptional Items 0 0 4.9 5.75 0
Profit Before Tax 152.04 136.95 99.64 -5.14 2.41
Tax 37.45 34.01 24.07 -2.1 5.41
Net Profit 114.59 102.94 75.58 -3.04 -3
Adjusted EPS (Rs.) 42.2 37.91 27.83 -1.1 -1.07

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 27.94 27.56 27.56 27.58 28
Total Reserves 474.74 575.57 638.48 637.3 633.61
Borrowings 74.71 93.97 58.86 74.16 50.69
Other N/C liabilities 21.44 27.46 34.35 32.92 38.13
Current liabilities 206.74 358.32 346.55 370.32 328.88
Total Liabilities 805.58 1082.88 1105.79 1142.28 1079.32
Assets
Net Block 477.57 508.88 609.8 630.49 644.49
Capital WIP 45.89 110.16 70.2 86.14 65.7
Intangible WIP 0 0 0 0 0
Investments 41.83 53.35 52.6 54.17 54.08
Loans & Advances 14.55 6.35 9.79 10.99 10.72
Other N/C Assets 0 0 0 0.06 0.05
Current Assets 225.73 404.14 363.4 360.44 304.28
Total Assets 805.58 1082.88 1105.79 1142.28 1079.32
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 152.04 136.95 94.75 -10.89 2.41
Adjustment 6.96 32.48 40.69 51.67 56.93
Changes in Assets & Liabilities -11.73 -152.98 64.68 45.52 -0.78
Tax Paid -32.7 -27.61 -17.57 -1.21 0
Operating Cash Flow 114.57 -11.17 182.54 85.09 58.56
Investing Cash Flow -135.38 -120.11 -90.63 -65.03 -27.06
Financing Cash Flow 21.89 145.61 -108.61 -23.12 -27.65
Net Cash Flow 1.08 14.34 -16.7 -3.05 3.85

Corporate Actions

Investors Details

PARTICULARS Sep 2024% Dec 2024% Mar 2025% Jun 2025% Sep 2025%
promoters 37.77 37.74 37.91 37.91 37.91
aakansha pharmachem llp 0.02 0.02 0.02 0.02 0.02
aarti corporate services ... 0.37 0.37 0.37 0.37 0.37
alchemie financial servic... 0.20 0.20 0.20 0.20 0.20
alchemie finserv pvt. ltd... 0.13 0.13 - 0.13 0.13
arti rajendra gogri 7.17 7.17 7.06 7.06 7.06
arvind kanji chheda 1.57 1.57 1.55 1.55 1.55
chandrakant vallabhaji go... 0.30 0.30 0.30 0.30 0.30
dhanvanti hemchand gala 0.18 0.18 0.18 0.18 0.18
dilesh roadlines pvt ltd 2.23 2.23 - 2.85 2.85
drl cargo carriers pvt lt... 0.06 0.06 - 0.11 0.11
hemchand lalji gala 0.42 0.42 0.42 0.42 0.42
hetal gogri gala 0.91 0.91 0.89 0.89 0.89
hiral arvind chheda 1.47 1.47 1.45 1.45 1.45
indira madan dedhia 0.13 0.13 0.13 0.13 0.13
jaya chandrakant gogri 8.38 8.37 8.25 8.25 8.25
manisha rashesh gogri 5.76 5.76 5.67 5.67 5.67
mirik rajendra gogri 2.43 2.43 2.39 2.39 2.39
paridhi business trust (s... - - - 0.46 0.46
pooja renil gogri 0.21 0.21 0.20 0.20 0.20
tulip family trust (gloir... - - - 2.19 2.19
ujjwal business trust (al... - - - 2.14 2.14
vicky hemchand gala 0.94 0.94 0.92 0.92 0.92
alabhya trusteeship priva... - 2.17 2.14 - -
alchemie finserv private ... - - 0.13 - -
dilesh roadlines private ... - - 2.85 - -
drl cargo carriers privat... - - 0.11 - -
gloire trusteeship servic... - 2.22 2.19 - -
saswat trusteeship privat... - 0.47 0.46 - -
paridhi business trust(sa... 0.47 - - - -
tulip family trust(gloire... 2.22 - - - -
ujjwal business trust(ala... 2.18 - - - -
PARTICULARS Sep 2024% Dec 2024% Mar 2025% Jun 2025% Sep 2025%
investors 62.23 62.26 62.09 62.09 62.09
bhanumati mohanlal savla 3.40 3.30 3.24 3.19 3.19
bhavesh dhirajlal sheth 1.23 1.22 1.21 1.21 1.21
bhaveshkumar bachubhai me... 2.24 2.24 2.29 2.29 2.29
harsha mahesh savadia 2.34 2.34 2.30 2.30 2.30
llp 0.08 0.04 0.09 0.10 0.11
mahesh mathuradas savadia... 1.95 1.95 1.92 1.92 1.92
meena manoj chheda 1.96 1.96 1.93 1.93 1.93
nikhil parimal desai 9.11 9.10 9.17 9.17 9.17
nipun harihar bhatt 1.07 1.07 - 1.06 1.06
nipun harihar bhat - - 1.06 - -
bavaria industries group ... 1.11 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2021
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
Research Monarch Networth Capital
Research Monarch Networth Capital
Research Monarch Networth Capital
Research Monarch Networth Capital
Research Monarch Networth Capital

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY23
Concall Q4FY22
Concall Q3FY24
Concall Q1FY23
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY22
Presentation Q4FY22
Presentation Q3FY24
Presentation Q3FY23
Presentation Q3FY22
Presentation Q3FY22
Presentation Q3FY22
Presentation Q2FY23
Presentation Q1FY26
Presentation Q1FY25
Presentation Q1FY25
Presentation Q1FY24

Company News

Valiant Organics informs about trading window closure 26 Dec, 3:31 PM Valiant Organics informs about newspaper clippings 15 Nov, 2:56 PM Valiant Organics - Quaterly Results 13 Aug, 5:07 PM Valiant Organics - Quaterly Results 13 Aug, 5:07 PM Valiant Organics - Quaterly Results 13 Aug, 5:07 PM Valiant Organics informs about compliance certificate 9 Jul, 4:52 PM Valiant Organics - Quaterly Results 22 May, 8:14 PM Valiant Organics - Quaterly Results 22 May, 8:14 PM Valiant Organics inks pact to acquire 26.25% stake in Pro-Zeal Green Power Eight 24 Apr, 4:00 PM Valiant Organics informs about certificate 5 Apr, 12:12 PM Valiant Organics - Quaterly Results 13 Feb, 5:16 PM Valiant Organics - Quaterly Results 13 Feb, 5:16 PM Valiant Organics submits board meeting intimation 6 Feb, 1:03 PM Valiant Organics informs about re-commencement of operations 20 Jan, 5:29 PM Valiant Organics informs about voting results of postal ballot 2 Jan, 5:24 PM Valiant Organics informs about investor presentation 3 Dec, 5:06 PM Valiant Organics informs about newspaper advertisement 3 Dec, 12:54 PM Valiant Organics - Quaterly Results 13 Aug, 6:52 PM Valiant Organics informs about investor presentation 17 Jun, 4:41 PM Valiant Organics - Quaterly Results 24 May, 9:37 PM Valiant Organics - Quaterly Results 24 May, 9:37 PM Valiant Organics informs about certificate 4 Apr, 5:32 PM Valiant Organics - Quaterly Results 13 Feb, 4:09 PM Valiant Organics - Quaterly Results 13 Feb, 4:09 PM Valiant Organics informs about earnings call transcript 16 Nov, 12:50 PM Valiant Organics informs about press release 10 Nov, 3:15 PM Valiant Organics informs about financial results 8 Nov, 5:01 PM Valiant Organics - Quaterly Results 8 Nov, 4:35 PM Valiant Organics - Quaterly Results 9 Aug, 4:43 PM Valiant Organics - Quaterly Results 9 Aug, 4:43 PM Valiant Organics - Quaterly Results 9 Aug, 4:43 PM Valiant Organics - Quaterly Results 19 May, 6:28 PM Valiant Organics - Quaterly Results 19 May, 6:28 PM Valiant Organics - Quaterly Results 31 Jan, 4:18 PM Valiant Organics - Quaterly Results 31 Jan, 4:18 PM Valiant Organics - Quaterly Results 31 Jan, 4:18 PM Valiant Organics - Quaterly Results 8 Nov, 2:43 PM Valiant Organics - Quaterly Results 8 Nov, 2:43 PM Valiant Organics - Quaterly Results 8 Nov, 2:43 PM Valiant Organics informs about analyst meet 29 Aug, 12:29 PM Valiant Organics informs about audio recording 8 Aug, 4:52 PM Valiant Organics informs about newspaper publication 6 Aug, 12:31 PM Valiant Organics - Quaterly Results 4 Aug, 6:28 PM Valiant Organics - Quaterly Results 4 Aug, 6:28 PM Valiant Organics - Quaterly Results 4 Aug, 6:28 PM Valiant Organics informs about board meeting 27 Jul, 5:00 PM Valiant Organics incorporates wholly owned subsidiary 11 Jul, 5:21 PM Valiant Organics - Quaterly Results 25 May, 8:32 PM Valiant Organics - Quaterly Results 25 May, 8:32 PM Valiant Organics informs about disclosure 5 Mar, 4:13 PM

Valiant Organics Stock Price Analysis and Quick Research Report. Is Valiant Organics an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Valiant Organics. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Valiant Organics has a PE ratio of 33.32604192133 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Valiant Organics has ROA of -0.2699% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Valiant Organics has a Current ratio of 0.9252.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Valiant Organics has a ROE of -0.4524%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Valiant Organics has a Debt to Equity ratio of 0.3196 which means that the company has low proportion of debt in its capital.

  • Sales growth: Valiant Organics has reported revenue growth of 6.1385% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Valiant Organics for the current financial year is 7.45107767274218%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Valiant Organics is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Valiant Organics is Rs 7.7717. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Valiant Organics in Ticker for free. Also, one can get the intrinsic value of Valiant Organics by using Valuation Calculators, which are available with a Finology ONE subscription. 

Valiant Organics FAQs

Q1. What is Valiant Organics share price today?
Ans: The current share price of Valiant Organics is Rs 259.

Q2. What is the market capitalisation of Valiant Organics?
Ans: Valiant Organics has a market capitalisation of Rs 725.707899 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Valiant Organics?
Ans: The PE ratio of Valiant Organics is 33.32604192133 and the P/B ratio of Valiant Organics is 1.07480653482373, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Valiant Organics share?
Ans: The 52-week high share price of Valiant Organics is Rs 507.8, and the 52-week low share price of Valiant Organics is Rs 227.05.

Q5. Does Valiant Organics pay dividends?
Ans: Currently, Valiant Organics does not pay dividends. Dividend yield of Valiant Organics is around 0%.

Q6. What are the face value and book value of Valiant Organics shares?
Ans: The face value of Valiant Organics shares is Rs 10, while the book value per share of Valiant Organics is around Rs 240.9736. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Valiant Organics?
Ans: Valiant Organics has a total debt of Rs 211.3569 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Valiant Organics?
Ans: The ROE of Valiant Organics is -0.4524% and ROCE of Valiant Organics is 2.9718%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Valiant Organics a good buy for the long term?
Ans: The Valiant Organics long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Valiant Organics undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Valiant Organics appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Valiant Organics’s financials?
Ans: You can review Valiant Organics’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Valiant Organics
X